Suppr超能文献

酒精性肝病中肠道微生物组和代谢组的改变。

Alterations of the gut microbiome and metabolome in alcoholic liver disease.

作者信息

Zhong Wei, Zhou Zhanxiang

机构信息

Wei Zhong, Zhanxiang Zhou, Center for Translational Biomedical Research, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, NC 28081, United States.

出版信息

World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):514-22. doi: 10.4291/wjgp.v5.i4.514.

Abstract

Alcohol consumption is one of the leading causes of liver diseases and liver-related death worldwide. The gut is a habitat for billions of microorganisms which promotes metabolism and digestion in their symbiotic relationship with the host. Alterations of gut microbiome by alcohol consumption are referred to bacterial overgrowth, release of bacteria-derived products, and/or changed microbiota equilibrium. Alcohol consumption also perturbs the function of gastrointestinal mucosa and elicits a pathophysiological condition. These adverse effects caused by alcohol may ultimately result in a broad change of gastrointestinal luminal metabolites such as bile acids, short chain fatty acids, and branched chain amino acids. Gut microbiota alterations, metabolic changes produced in a dysbiotic intestinal environment, and the host factors are all critical contributors to the development and progression of alcoholic liver disease. This review summarizes recent findings of how alcohol-induced alterations of gut microbiota and metabolome, and discusses the mechanistic link between gastrointestinal dyshomeostasis and alcoholic liver injury.

摘要

饮酒是全球肝脏疾病和肝脏相关死亡的主要原因之一。肠道是数十亿微生物的栖息地,它们在与宿主的共生关系中促进新陈代谢和消化。饮酒引起的肠道微生物群改变包括细菌过度生长、细菌衍生产物的释放和/或微生物群平衡的改变。饮酒还会扰乱胃肠道黏膜的功能并引发病理生理状况。酒精引起的这些不良反应最终可能导致胃肠道腔内代谢物如胆汁酸、短链脂肪酸和支链氨基酸发生广泛变化。肠道微生物群改变、在肠道生态失调环境中产生的代谢变化以及宿主因素都是酒精性肝病发生和发展的关键因素。本综述总结了酒精引起的肠道微生物群和代谢组改变的最新研究结果,并讨论了胃肠道内稳态失调与酒精性肝损伤之间的机制联系。

相似文献

1
Alterations of the gut microbiome and metabolome in alcoholic liver disease.
World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):514-22. doi: 10.4291/wjgp.v5.i4.514.
2
Gut microbiota and host metabolism in liver cirrhosis.
World J Gastroenterol. 2015 Nov 7;21(41):11597-608. doi: 10.3748/wjg.v21.i41.11597.
4
Interactions between the intestinal microbiome and liver diseases.
Gastroenterology. 2014 May;146(6):1513-24. doi: 10.1053/j.gastro.2014.01.020. Epub 2014 Jan 15.
5
The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non-Alcoholic Fatty Liver Disease.
Mol Nutr Food Res. 2020 Sep;64(17):e2000375. doi: 10.1002/mnfr.202000375. Epub 2020 Aug 10.
6
The gut-liver axis in liver disease: Pathophysiological basis for therapy.
J Hepatol. 2020 Mar;72(3):558-577. doi: 10.1016/j.jhep.2019.10.003. Epub 2019 Oct 14.
7
Alcohol, liver disease and the gut microbiota.
Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):235-246. doi: 10.1038/s41575-018-0099-1.
10
Microbiome as a therapeutic target in alcohol-related liver disease.
J Hepatol. 2019 Feb;70(2):260-272. doi: 10.1016/j.jhep.2018.10.019.

引用本文的文献

1
Safety and efficacy of probiotics in the treatment of ALD.
Medicine (Baltimore). 2025 Aug 8;104(32):e43662. doi: 10.1097/MD.0000000000043662.
2
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD.
Antioxidants (Basel). 2025 Jan 6;14(1):56. doi: 10.3390/antiox14010056.
4
The alcohol exposome.
Alcohol. 2025 Feb;122:81-89. doi: 10.1016/j.alcohol.2024.12.003. Epub 2024 Dec 23.
5
Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases.
Gastro Hep Adv. 2023 Oct 6;3(3):344-352. doi: 10.1016/j.gastha.2023.09.013. eCollection 2024.
6
Role of Immunological Cells in Hepatocellular Carcinoma Disease and Associated Pathways.
ACS Pharmacol Transl Sci. 2023 Nov 8;6(12):1801-1816. doi: 10.1021/acsptsci.3c00216. eCollection 2023 Dec 8.
7
Alcohol-associated bowel disease: new insights into pathogenesis.
eGastroenterology. 2023 Jun;1(1). doi: 10.1136/egastro-2023-100013. Epub 2023 Aug 18.
8
Difference and clinical value of metabolites in plasma and feces of patients with alcohol-related liver cirrhosis.
World J Gastroenterol. 2023 Jun 14;29(22):3534-3547. doi: 10.3748/wjg.v29.i22.3534.
9
Capacity of a Microbial Synbiotic To Rescue the Metabolic Activity of the Gut Microbiome following Perturbation with Alcohol or Antibiotics.
Appl Environ Microbiol. 2023 Mar 29;89(3):e0188022. doi: 10.1128/aem.01880-22. Epub 2023 Feb 22.
10

本文引用的文献

2
Host-microbiome interactions in alcoholic liver disease.
Gut Liver. 2014 May;8(3):237-41. doi: 10.5009/gnl.2014.8.3.237.
3
Elucidating the interactions between the human gut microbiota and its host through metabolic modeling.
Front Genet. 2014 Apr 22;5:86. doi: 10.3389/fgene.2014.00086. eCollection 2014.
4
The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome.
Front Endocrinol (Lausanne). 2014 Apr 7;5:47. doi: 10.3389/fendo.2014.00047. eCollection 2014.
5
Lactobacillus casei MYL01 modulates the proinflammatory state induced by ethanol in an in vitro model.
J Dairy Sci. 2014;97(4):2009-16. doi: 10.3168/jds.2013-7514. Epub 2014 Jan 31.
6
Interactions between the intestinal microbiota and innate lymphoid cells.
Gut Microbes. 2014 Jan-Feb;5(1):129-40. doi: 10.4161/gmic.27289. Epub 2013 Dec 16.
7
The role of short-chain fatty acids in health and disease.
Adv Immunol. 2014;121:91-119. doi: 10.1016/B978-0-12-800100-4.00003-9.
8
The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth.
Dig Dis Sci. 2014 Mar;59(3):638-44. doi: 10.1007/s10620-013-2960-y. Epub 2013 Dec 10.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验